Abstract:BACKGROUND:Although the clinical importance of demonstrating the presence of anti-glomerular basement membrane (anti-GBM) antibodies is well established, less is known concerning the clinical utility of measuring the levels of autoantibodies. Two conformational epitopes of anti-GBM antibodies have been defined at residues 17-31 and 127-141 of the alpha3(IV)NC1 domain of type IV collagen [alpha3(IV)NC1], which were named as EA and EB, respectively. In order to elucidate the importance of such antibodies, we studied the levels and the epitope specificities of anti-GBM antibodies in a large cohort of Chinese patients with anti-GBM disease. METHODS:All patients, with anti-GBM disease and available clinical data, diagnosed at Peking University First Hospital from 1996 to 2005 were included in the present study. Recombinant chimeric proteins containing previously defined epitope regions designated as EA and EB were used to detect anti-GBM antibodies by ELISA. Results were compared and correlated with clinical data collected at the time of diagnosis, biopsy findings and outcome after 1 year of follow-up. RESULTS:A retrospective diagnosis of anti-GBM disease was made in 147 patients. Haemoptysis was recorded for 47% of these cases while 53.5% cases had oliguria or anuria at the time of diagnosis. Among these patients, the levels of anti-GBM antibodies correlated with serum creatinine at diagnosis (P < 0.05 for anti EA, EB and alpha3(IV)NC1). Oliguric patients had higher levels of autoantibodies than non-oliguric patients, however, the difference being statistically significant only for EB (P < 0.05). Renal biopsies were performed in 66 patients, and it was found that 50 (75.8%) had cresent formation in >85% of the glomeruli. There was a correlation between the percentage of crescents and levels of antibodies, but it was significant only for anti-EA antibodies (P < 0.05). Clinical data regarding the follow-up were available for 102 patients; at the end of 1 year, 88 (86.3%) were either dead or dialysis dependent. The absorbance values of anti-GBM antibodies against both EA and EB were also associated with the subsequent development, death or terminal renal insufficiency (P < 0.05). CONCLUSION:In this study, patients with high levels of circulating antibodies against the specific epitopes EA and EB had a more severe renal disease at diagnosis as well as a worse prognosis.

Circulating Anti‐glomerular Basement Membrane Autoantibodies Against Α3(iv)nc1 Undetectable by Commercially Available Enzyme‐linked Immunosorbent Assays

The Prevalence and Characteristics of Circulating IgA Anti-Glomerular Basement Membrane Autoantibodies in Anti-Glomerular Basement Membrane Disease

Natural Anti-Gbm Antibodies from Normal Human Sera Recognize Α3(iv)nc1 Restrictively and Recognize the Same Epitopes As Anti-Gbm Antibodies from Patients with Anti-Gbm Disease

Anti-glomerular Basement Membrane Autoantibodies Against Different Target Antigens Are Related to Patients' Clinical Phenotype

Comparison of the Performance of a Chemiluminescence Assay and an ELISA for Detection of Anti-Gbm Antibodies

Avidity of Anti-Glomerular Basement Membrane Autoantibodies Was Associated with Disease Severity.

The Prevalence and Immunological Features of Anti-Glomerular Basement Membrane Antibody in Patients with HIV/AIDS

Epitopes of Anti-Glomerular Basement Membrane Autoantibodies Are Related with the Severity of Renal Damage

Natural Autoantibodies Against Glomerular Basement Membrane Exist in Normal Human Sera

Levels of Epitope-Specific Autoantibodies Correlate with Renal Damage in Anti-Gbm Disease

Epitope recognized by anti-glomerular basement membrane (GBM) antibody in a patient with repeated relapse of anti-GBM disease

The prevalence and immunological features of anti-glomerular basement membrane antibody in patients with HIV

Anti-glomerular Basement Membrane-Antibody Mediated Disease with Normal Renal Function——3 Cases Report

Natural Autoantibodies to Myeloperoxidase, Proteinase 3, and the Glomerular Basement Membrane Are Present in Normal Individuals.

Antibodies Against Linear Epitopes on the Goodpasture Autoantigen and Kidney Injury.

Plasma From Patients With Anti-Glomerular Basement Membrane Disease Could Recognize Microbial Peptides

Identification of Critical Residues of Linear B Cell Epitope on Goodpasture Autoantigen

Performance Evaluation of a Novel Chemiluminescence Assay for Detection of Anti-Gbm Antibodies: an International Multicenter Study.

Avidity of Anti-Glomerular Basement Membrane Autoantibodies Was Associated with Renal Pathological Damage

[The Heterogeneity of Anti-Gbm Autoantibodies in Sera from Patients with Anti-Gbm Disease and Its Clinical Correlation].

Glomerular C1q Deposition and Serum Anti-C1q Antibodies in Anti-Glomerular Basement Membrane Disease.